An anti-choice bill passed Wednesday by a Kansas legislative committee could have broad implications for how all health care—not just reproductive care—is provided.
The ruling means a 2011 law that bans off-label use of abortion-inducting medications can take effect immediately.
Michigan lawmakers push through an anti-democratic new abortion restriction, while the Senate actually gets some work done.
A Pennsylvania nurse has been accused of “performing an illegal abortion on a 16-year-old girl,” according to a local report out of Montour county.
Attorneys for the State of North Dakota defended the state’s 2011 medication abortion ban by arguing North Dakota women have no state constitutional right to an abortion.
To be published in the journal Contraception, the research concludes women having second trimester medication abortions face no increased risk of future premature birth, miscarriage, low birth weight, or placental complications when compared to first trimester medication abortions.
There is much we can learn from our sisters in the Global South who, rather than trying to gain access to services that all too often do not exist or fail to treat them well, are obtaining pills to induce abortion and taking them at home without seeing a health provider.
If we have a cheap and readily available drug that can prevent and treat the two largest causes of maternal mortality worldwide—postpartum hemorrhage and unsafe abortion—why have we not taken more advantage of it?
Reproductive rights advocates scored a couple of victories last week while the Supreme Court considers the impact of allowing patents on human genetic material.
After a short and unsurprising debate, the Indiana Senate voted 33 to 16 to pass a bill that will force all clinics that provide RU-486 for early abortions to become licensed surgical abortion facilities, regardless of whether or not they offer surgical abortions.